Metlife (MET) Gets Credit Suisse Civerage with $67.0000 Target; 8 Analysts Covering United Natural Foods, Inc. (UNFI)

April 26, 2018 - By Annabelle Johnson

United Natural Foods, Inc. (NASDAQ:UNFI) Logo

New York: Metlife (NYSE:MET) coverage was was started with a “Buy” rating and $67.0000 price target at Credit Suisse. Credit Suisse’s PT gives upside of 40.08% from the company’s last close price.

Among 26 analysts covering United Natural Foods (NASDAQ:UNFI), 8 have Buy rating, 4 Sell and 14 Hold. Therefore 31% are positive. United Natural Foods had 90 analyst reports since July 21, 2015 according to SRatingsIntel. As per Tuesday, January 16, the company rating was maintained by Stephens. As per Friday, February 2, the company rating was maintained by RBC Capital Markets. The stock of United Natural Foods, Inc. (NASDAQ:UNFI) has “Hold” rating given on Tuesday, September 19 by RBC Capital Markets. Jefferies maintained United Natural Foods, Inc. (NASDAQ:UNFI) rating on Thursday, November 5. Jefferies has “Buy” rating and $61.0 target. The firm has “Perform” rating by Oppenheimer given on Tuesday, December 8. The company was downgraded on Wednesday, July 22 by Morgan Stanley. The firm earned “Hold” rating on Friday, December 8 by BMO Capital Markets. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, March 8. The stock has “Hold” rating by RBC Capital Markets on Tuesday, August 29. The rating was downgraded by Oppenheimer to “Perform” on Tuesday, July 21. See United Natural Foods, Inc. (NASDAQ:UNFI) latest ratings:

12/03/2018 Broker: BMO Capital Markets Old Rating: Market Perform New Rating: Market Perform Old Target: $57 New Target: $50 Maintain
09/03/2018 Broker: Jefferies Rating: Hold New Target: $53.0 Maintain
08/03/2018 Broker: BMO Capital Markets Rating: Hold New Target: $57.0 Maintain
02/02/2018 Broker: RBC Capital Markets Rating: Sell New Target: $38.0 Maintain
24/01/2018 Broker: BMO Capital Markets Rating: Hold New Target: $57.0 Maintain
16/01/2018 Broker: Stephens Rating: Hold New Target: $51.0 Maintain
16/01/2018 Broker: Barclays Capital Rating: Hold New Target: $43.0 Upgrade
11/01/2018 Broker: Susquehanna Rating: Hold New Target: $51.0 Maintain
08/12/2017 Broker: BMO Capital Markets Rating: Hold New Target: $54.0 Maintain
08/12/2017 Broker: Jefferies Rating: Hold New Target: $47.0 Maintain

Investors sentiment increased to 1.02 in Q4 2017. Its up 0.13, from 0.89 in 2017Q3. It increased, as 45 investors sold MetLife, Inc. shares while 330 reduced holdings. 93 funds opened positions while 290 raised stakes. 782.94 million shares or 0.24% less from 784.85 million shares in 2017Q3 were reported. Central Retail Bank Trust stated it has 0% of its portfolio in MetLife, Inc. (NYSE:MET). Robeco Institutional Asset Management Bv invested in 0.11% or 435,724 shares. Hartford Fincl Mgmt Inc holds 0% or 42 shares in its portfolio. Pictet Asset Mngmt Limited holds 627,690 shares. 422,406 are held by Capital Investors. First Corporation In, Indiana-based fund reported 1,926 shares. 365,459 are owned by Riverpoint Mgmt Limited Liability Company. Capital Fund Mgmt Sa accumulated 13,292 shares. Hightower has invested 0.13% in MetLife, Inc. (NYSE:MET). Stack Mgmt invested in 242,609 shares. Ckw Fincl Group invested in 2,200 shares. Cipher Capital L P has 10,328 shares for 0.04% of their portfolio. Proshare Advsrs Ltd Com owns 314,302 shares or 0.11% of their US portfolio. Schwab Charles Mgmt accumulated 3.71M shares. Epoch Invest Ptnrs holds 1.77% of its portfolio in MetLife, Inc. (NYSE:MET) for 10.58M shares.

Among 19 analysts covering MetLife (NYSE:MET), 11 have Buy rating, 1 Sell and 7 Hold. Therefore 58% are positive. MetLife has $7800 highest and $46 lowest target. $57.53’s average target is 20.28% above currents $47.83 stock price. MetLife had 57 analyst reports since July 31, 2015 according to SRatingsIntel. Argus Research maintained the shares of MET in report on Wednesday, August 9 with “Buy” rating. RBC Capital Markets maintained MetLife, Inc. (NYSE:MET) rating on Monday, July 10. RBC Capital Markets has “Buy” rating and $6200 target. Raymond James upgraded MetLife, Inc. (NYSE:MET) on Friday, January 22 to “Strong Buy” rating. As per Friday, November 3, the company rating was maintained by Morgan Stanley. As per Monday, July 10, the company rating was maintained by Wells Fargo. The rating was maintained by Wells Fargo on Tuesday, October 3 with “Buy”. As per Tuesday, January 19, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating given on Friday, May 5 by Wells Fargo. Bank of America initiated MetLife, Inc. (NYSE:MET) on Monday, March 26 with “Hold” rating. On Friday, November 10 the stock rating was downgraded by Sandler O’Neill to “Hold”.

The stock increased 0.46% or $0.22 during the last trading session, reaching $47.83. About 4.91M shares traded. MetLife, Inc. (NYSE:MET) has declined 1.24% since April 26, 2017 and is downtrending. It has underperformed by 12.79% the S&P500.

MetLife, Inc., through its subsidiaries, provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. The company has market cap of $49.58 billion. It operates in six divisions: U.S.; Asia; Latin America; Europe, the Middle East, and Africa; MetLife Holdings; and Brighthouse Financial. It has a 13.23 P/E ratio. The firm offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, and critical illness insurance products; vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only and private floating rate funding agreements; and account guaranteed, separate account guaranteed, and trust guaranteed interest contracts.

Analysts await MetLife, Inc. (NYSE:MET) to report earnings on May, 2 after the close. They expect $1.17 earnings per share, down 19.86% or $0.29 from last year’s $1.46 per share. MET’s profit will be $1.21 billion for 10.22 P/E if the $1.17 EPS becomes a reality. After $1.11 actual earnings per share reported by MetLife, Inc. for the previous quarter, Wall Street now forecasts 5.41% EPS growth.

Investors sentiment decreased to 1.08 in 2017 Q4. Its down 0.17, from 1.25 in 2017Q3. It turned negative, as 31 investors sold United Natural Foods, Inc. shares while 82 reduced holdings. 46 funds opened positions while 76 raised stakes. 51.64 million shares or 4.49% less from 54.07 million shares in 2017Q3 were reported. 12,630 were reported by Rowland And Co Counsel Adv. Rhumbline Advisers owns 106,745 shares or 0.01% of their US portfolio. Shaker Invs Lc Oh reported 36,605 shares. Ameritas Invest Prtnrs reported 19,496 shares stake. Citigroup reported 7,647 shares stake. Glob X Mngmt Limited Liability Corporation stated it has 685 shares. Clearbridge Ltd Company, a New York-based fund reported 801 shares. Balasa Dinverno & Foltz Lc invested in 0.05% or 7,093 shares. 9,276 were accumulated by Pub Employees Retirement Association Of Colorado. Goldman Sachs Group Inc, a New York-based fund reported 570,183 shares. Moreover, Barclays Public Limited Com has 0% invested in United Natural Foods, Inc. (NASDAQ:UNFI) for 99,984 shares. Century holds 0.03% or 527,689 shares in its portfolio. The Minnesota-based Ameriprise Fin has invested 0.02% in United Natural Foods, Inc. (NASDAQ:UNFI). Martingale Asset Mngmt Lp owns 48,348 shares or 0.03% of their US portfolio. Bnp Paribas Arbitrage Sa invested in 32,568 shares.

Since December 12, 2017, it had 0 buys, and 12 sales for $5.88 million activity. Green Paul Scott sold $171,323 worth of United Natural Foods, Inc. (NASDAQ:UNFI) on Wednesday, January 3. Shares for $254,133 were sold by Traficanti Joseph J. The insider SPINNER STEVEN sold $2.43 million. $234,686 worth of United Natural Foods, Inc. (NASDAQ:UNFI) was sold by TESTA CHRISTOPHER P. on Tuesday, January 2. $394,236 worth of stock was sold by HEFFERNAN JAMES P on Monday, December 18. 6,253 United Natural Foods, Inc. (NASDAQ:UNFI) shares with value of $310,086 were sold by SMITH CRAIG HARDER. Shares for $137,810 were sold by ROY PETER.

MetLife, Inc. (NYSE:MET) Institutional Positions Chart